PEDVAXHIB CPT Vaccine Code: 90647

Vaccine & Product Overview

HCPCS Descriptor Haemophilus influenzae type b vaccine (Hib), PRP-OMP conjugate, 3 dose schedule, for intramuscular use

Manufacturer Merck Sharp & Dohme Corp

Route of Administration Intramuscular

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Injection, Suspension

About PEDVAXHIB

Pedvaxhib is a medication aligned to the HCPCS CPT Drug Code: 90647 for billing, pricing, and reimbursement purposes in the United States. This Vaccine medication is administered via the intramuscular route and manufactured by Merck Sharp & Dohme Corp.

Manufacturers, reach out to us to add more information.

NDC Code Information

1 NDC package is crosswalked to 90647. Package detail is available to logged-in subscribers.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
•••••-••••-•• Log in to view	PEDVAXHIB

Login to view 1 NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

PEDVAXHIB Pricing & Reimbursement

90647 Private Payer Reimbursement

$35.15 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

PEDVAXHIB Vaccine Administration Codes

CPT Code	Description
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), one vaccine (single or combination vaccine/toxoid)
90472	Immunization administration (each additional vaccine or toxoid), when performed in conjunction with primary procedure.

PEDVAXHIB Medically Unlikely Edits (MUE)

The most billing units of 90647 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 dose.

Practitioner Office & Hospital Outpatient

1 unit / day

Same limit in both settings

MAI 2 · Date of Service Edit: Policy. Absolute per-day limit set by policy or regulation; units above it are not payable, and denials are not appealable on medical-necessity grounds. See all MUE limits →

PEDVAXHIB Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Invasive disease caused by Haemophilus influenzae type b (Hib)

Drug Class

Actively Acquired Immunity [PE]Haemophilus Vaccines [CS]Inactivated Haemophilus Influenzae B Vaccine [EPC]VaccinesInactivated [CS]

Frequently Asked Questions

Is there an available Pedvaxhib billing and coding guide?

Billing and coding information for PEDVAXHIB can be found through Merck. Visit Here →

Are there any available Pedvaxhib patient assistance programs?

PEDVAXHIB patient assistance information can be found through Merck. Visit Here →

Where can I find Pedvaxhib prescribing information?

PEDVAXHIB prescribing information can be found at the link below: Visit Here →

Where can I find Pedvaxhib side effect information?

Our team has not yet identified a source of side effects information for PEDVAXHIB. Please check back in a few weeks.

Does billing PEDVAXHIB require JZ/JW wastage modifiers?

CMS does not include PEDVAXHIB (90647) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing 90647. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.